No Image Provided

Desktop Genetics

VC Funding

Seed

Healthcare & Biotech Published 1 December 2015

Summary

In a significant market movement during December 2015, Desktop Genetics was the subject of a vc funding. Leading the round was Illumina.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Illumina

Advising Broker

Undisclosed Firm

Seed prioritised

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

Tortus

£3,329,083

Feb 2024

VC Funding

Reactec

£725,784

Oct 2020

VC Funding

Luna Pet Healthcare

£700,000

May 2026

View Company Details

Financials, officers, full deal history

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.